Banner

1. Evaluation of antitumor efficacy of Cerium oxide nanoparticle on Ehrlich tumour cells in mice. J Popul Ther Clin Pharmacol Vol 30(5):e378–e390; 09 March 2023

J Popul Ther Clin Pharmacol Vol 30(9):e187–e197; 20 April 2023 • 2023
Back
Publication Information
Authors AbdEl-Aziz S.M, A.A. Baiomy, A. B. Mansour, R. H. Hanan, S. A. Ali, H. F. Attia, Gehan B. A. Youssef .
Keywords Cobalt oxide nanoparticles, Cytogenotoxicity, Comet assay, Liver
Journal J Popul Ther Clin Pharmacol Vol 30(9):e187–e197; 20 April 2023
Publisher Not Available
Volume 30
Issue 9
Pages 187-197
publication.type International
Paper Link Not Available
Supplementary Materials Not Available
Abstract
This study was done on 4 groups of mice to evaluate the cytogenotoxicity of cobalt oxide nanoparticles
by comet assay from liver tissue and bone marrow to detect DNA damage and the histopathological
changes in the hepatic tissues. Significant elevation in %DNA, tail length, and tail moment in liver
while in bone marrow the %DNA, tail length, and tail moment showed elevation in 5% cobalt oxide
nanoparticles and decline in 10% and 20% of cobalt oxide nanoparticles. The liver tissues of the 5%
cobalt nanoparticle group had areas of hepatocellular necrosis, focal aggregations of mononuclear
inflammatory cells, and portal congestion, whereas the 10% cobalt oxide nanoparticle group had
marked inflammatory cell infiltration, marked vascular congestion, and small focal areas of
hepatocellular necrosis that were infiltrated by mononuclear inflammatory cells. The hepatic tissue
parenchyma in the 20% cobalt oxide nanoparticles group had clogged blood arteries, and regions of
hepatocellular necrosis with mononuclear inflammatory cell infiltration were often seen lesions in the
liver. Some liver tissues, however, showed only little improvement. In conclusion the cobalt oxide
nanoparticles were showed cytotoxicity and genotoxicity especially in concentration of 5% and 10%.